Merck’s MF/F Phase III study data presented at AAAAI annual meeting (News-Medical-Net)

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

See original here:
Merck’s MF/F Phase III study data presented at AAAAI annual meeting (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------

A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly …

The recent emergence and rapid spread of a novel swine-derived H1N1 influenza virus has resulted in the first influenza pandemic of this century. Monovalent vaccines have undergone preclinical and clinical development prior to initiation of mass. … at the National Institutes of Health have found. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) developed the vaccine because there is no vaccine or treatment for chikungunya virus infection. …

Read more:
A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly …

----------------------------------------------------------------------------------------------------------------------------------------------------

Clinical trial of 2009 H1N1 influenza vaccine (News-Medical-Net)

HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.

Read the original:
Clinical trial of 2009 H1N1 influenza vaccine (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------

About 47M Infected, 10000 Dead From H1N1 In U.S., CDC Says …

US health officials on Thursday announced nearly 10000 people in the US had died from H1N1 (swine flu) since the virus was first reported in April, the New York Times reports. … The Future of Global HIV Treatment and Prevention The event will include a presentation by Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, on “the current status of HIV/AIDS treatment and prevention, followed by a rountable discussion.” 12/14 …

Continue reading here:
About 47M Infected, 10000 Dead From H1N1 In U.S., CDC Says …

----------------------------------------------------------------------------------------------------------------------------------------------------

Previous flu infections can reduce the severity of H1N1 (News-Medical-Net)

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 “swine” flu. “The question we asked was, “Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?,” said Alessandro Sette, Ph.D., an internationally recognized vaccine …

View post:
Previous flu infections can reduce the severity of H1N1 (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------

La Jolla Institute finds previous seasonal flu infections may provide some level of H1N1 immunity (EurekAlert!)

( La Jolla Institute for Allergy and Immunology ) Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 “swine” flu.

Here is the original post:
La Jolla Institute finds previous seasonal flu infections may provide some level of H1N1 immunity (EurekAlert!)

----------------------------------------------------------------------------------------------------------------------------------------------------

NexBio(R) Presents Data Showing Anti-Asthma Activity Of DAS181 (Fludase(R)) At ACAAI 2009 (Medical News Today)

NexBio, Inc. announced the presentation of new data at the 2009 annual American College of Allergy, Asthma, and Immunology in Miami, Florida. The presentation was entitled “DAS181 (Fludase®), a Sialidase, Decreases Airway Resistance and Has Potent Anti-inflammatory Effects in Animal Models of Asthma”.

The rest is here:
NexBio(R) Presents Data Showing Anti-Asthma Activity Of DAS181 (Fludase(R)) At ACAAI 2009 (Medical News Today)

----------------------------------------------------------------------------------------------------------------------------------------------------

Swine Flu (H1N1) Prevention and Treatments « Natural Mountain …

Heel Engystol Tablets: Part of our Heel Allergy Relief Kit, these tablets provide natural treatment for symptoms of viral infections, feverish conditions, and skin disorders through stimulation of your defense system. …

See the rest here:
Swine Flu (H1N1) Prevention and Treatments « Natural Mountain …

----------------------------------------------------------------------------------------------------------------------------------------------------

In Children, 2009 H1N1 Influenza Vaccine Works Like Seasonal Flu Vaccine – Early Results (Medical News Today)

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Read the original here:
In Children, 2009 H1N1 Influenza Vaccine Works Like Seasonal Flu Vaccine – Early Results (Medical News Today)

----------------------------------------------------------------------------------------------------------------------------------------------------

Early Results: In Children, 2009 H1N1 Influenza Vaccine Works Like Seasonal Flu Vaccine (BioresearchOnline)

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Go here to read the rest:
Early Results: In Children, 2009 H1N1 Influenza Vaccine Works Like Seasonal Flu Vaccine (BioresearchOnline)

----------------------------------------------------------------------------------------------------------------------------------------------------